HUMAN B CELL TRANSFORMATION BY EPSTEIN BARR VIRUS

爱泼斯坦巴尔病毒对人类 B 细胞的转化

基本信息

  • 批准号:
    2895164
  • 负责人:
  • 金额:
    $ 10.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-07-01 至 2000-06-30
  • 项目状态:
    已结题

项目摘要

Epstein-Barr Virus (EBV) is a human pathogen that is causally associated with both benign and malignant B-cell lymphoproliferations and nasopharyngeal carcinoma. Immunocompromised individuals such as AIDS patients and transplant recipients are at high risk for developing EBV- associated B-cell lymphomas. Virally-induced alterations of the growth properties of infected B-cells are likely to underlie EBV's contribution to these lymphoproliferative disorders. Infection of primary human B- cells in vitro EBV results in activation of the resting B-cell from a quiescent state to one of proliferation. These infected cells enter the cell cycle and are able to proliferate indefinitely and thus are immortalized. EBV is unique in its ability to immortalize primary resting B-cells in vitro. Entry of EBV-infected B-cells into the cell cycle and maintenance of the proliferative state of the cell is absolutely dependent upon viral gene expression. The overall aim of this proposal is to analyze the contribution of one particular gene product (LMP-1) of EBV to immortalization. The study of LMP-1 is of particular significance for the following reasons: 1) LMP-1 is one of 4 latent gene products, and the only membrane protein, shown to be essential for immortalization by EBV; ii) LMP-1 has profound effects on the growth of cells in culture (i.e., LMP-1 functions as an oncogene in rodent cells); iii) LMP-1 is located in the plasma membrane where it is associated, via its cytoplasmic amino- terminus, with the cytoskeleton. LMP-1 must interact with cell signal transduction pathways regulating normal B-cell proliferation and thus is the ideal starting point for identifying signaling pathways involved in immortalization by EBV. The specific objectives of this work are to use biochemical and genetic analyses of LMP-1 to: i) determine the transmembrane topology of LMP-1; ii) study the quaternary structure of LMP-1 and its relevance to function; and iii) determine the relationship between the structure of LMP-1's amino- and carboxy-termini and function, cytoskeletal association, turnover and patching. These experiments are expected to provide information that will aid in the identification of LMP-1's biochemical activity that results in altered cellular phenotypes and should allow the generation of rational models of how LMP-1 may function in EVB-mediated immortalization. Understanding the signal transduction mechanisms resulting B-cell immortalization by EBV will provide insights into the cellular mechanisms controlling the normal and malignant proliferative status of human B-cells, and may provide the basis for clinically relevant research aimed at the development of therapies for the prevention and treatment of EBV-dependent lymphomas as well as other virally and nonvirally induced malignancies.
EB病毒(EBV)是一种人类病原体, 良性和恶性B细胞淋巴增生, 鼻咽癌 免疫力低下的人,如艾滋病 患者和移植受者患EBV的风险很高, 相关的B细胞淋巴瘤。 病毒引起的生长变化 受感染的B细胞的特性可能是EBV的作用的基础 淋巴组织增生性疾病 原发性人B- 细胞体外EBV导致静息B细胞活化, 从静止状态转变为增殖状态。 这些受感染的细胞进入 细胞周期,能够无限增殖,因此, 不朽 EB病毒是独一无二的,它能够使原发性静息 体外B细胞。 EBV感染的B细胞进入细胞周期, 细胞增殖状态的维持完全依赖于 病毒基因的表达。 本建议的总体目标是 分析EBV的一种特定基因产物(LMP-1)对 永生 LMP-1的研究对人类的免疫学研究具有重要意义。 原因如下:1)LMP-1是4种潜在基因产物之一,也是唯一的 膜蛋白,显示为EBV永生化所必需; ii) LMP-1对培养物中细胞的生长具有深远的影响(即,LMP-1 在啮齿动物细胞中作为致癌基因起作用); iii)LMP-1位于 质膜,通过其细胞质氨基, 末端,与细胞骨架。 LMP-1必须与细胞信号相互作用 调节正常B细胞增殖的转导途径, 这是识别参与的信号通路的理想起点, EB病毒永生化。 这项工作的具体目标是使用 LMP-1的生物化学和遗传分析,以:i)确定 ii)研究LMP-1的四级结构; LMP-1及其与功能的相关性;以及iii)确定 LMP-1的氨基和羧基末端的结构与功能之间, 细胞骨架结合、周转和修补。 这些实验 预计将提供有助于识别 LMP-1的生化活性导致细胞表型改变 并应允许生成LMP-1如何 在EVB介导的永生化中发挥作用。 了解信号 EBV导致B细胞永生化的转导机制将 提供了对控制正常细胞的细胞机制的见解, 人类B细胞的恶性增殖状态,并可能提供基础 用于临床相关研究,旨在开发治疗 预防和治疗EBV依赖性淋巴瘤以及其他 病毒和非病毒引起的恶性肿瘤。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.
肿瘤病毒分离株中意外缺乏 Epstein-Barr 病毒 (EBV) lyLMP-1 开放阅读框:Met129 状态与 EBV 毒株身份之间缺乏相关性。
  • DOI:
    10.1128/jvi.77.7.4415-4422.2003
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Erickson,KimberlyD;Berger,Christoph;Coffin3rd,WilliamF;Schiff,Edwin;Walling,DennisM;Martin,JenniferM
  • 通讯作者:
    Martin,JenniferM
Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions.
  • DOI:
    10.1099/vir.0.19156-0
  • 发表时间:
    2003-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Golnar Vazirabadi;Timothy R. Geiger;W. Coffin;Jennifer M. Martin
  • 通讯作者:
    Golnar Vazirabadi;Timothy R. Geiger;W. Coffin;Jennifer M. Martin
Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
在 EBV 感染的 B 细胞中早期检测到裂解性 LMP-1 蛋白表明其存在于病毒颗粒中。
  • DOI:
    10.1006/viro.1997.8638
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Erickson,KD;Martin,JM
  • 通讯作者:
    Martin,JM
Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
EBV 阴性霍奇金病细胞系 L-428 中 LMP1 癌蛋白的表达与 Reed-Sternberg 细胞形态相关。
  • DOI:
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Knecht,H;McQuain,C;Martin,J;Rothenberger,S;Drexler,HG;Berger,C;Bachmann,E;Kittler,EL;Odermatt,BF;Quesenberry,PJ
  • 通讯作者:
    Quesenberry,PJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNIFER M MARTIN其他文献

JENNIFER M MARTIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNIFER M MARTIN', 18)}}的其他基金

Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    7940101
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    7629814
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    8055263
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    7934190
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    7934191
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    8051416
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago
用合成肽 Antago 探测 EBV-LMP-1 的跨膜激活域
  • 批准号:
    7804469
  • 财政年份:
    2009
  • 资助金额:
    $ 10.61万
  • 项目类别:
Activation of the LMP-1 Protein of Epstein-Barr Virus
Epstein-Barr 病毒 LMP-1 蛋白的激活
  • 批准号:
    6880020
  • 财政年份:
    2004
  • 资助金额:
    $ 10.61万
  • 项目类别:
Activation of the LMP-1 Protein of Epstein-Barr Virus
Epstein-Barr 病毒 LMP-1 蛋白的激活
  • 批准号:
    7215749
  • 财政年份:
    2004
  • 资助金额:
    $ 10.61万
  • 项目类别:
Activation of the LMP-1 Protein of Epstein-Barr Virus
Epstein-Barr 病毒 LMP-1 蛋白的激活
  • 批准号:
    7574812
  • 财政年份:
    2004
  • 资助金额:
    $ 10.61万
  • 项目类别:

相似海外基金

Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
  • 批准号:
    10910338
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
  • 批准号:
    10829620
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
  • 批准号:
    10889325
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
  • 批准号:
    10755205
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
  • 批准号:
    489085
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
    Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
  • 批准号:
    10679118
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
  • 批准号:
    10755055
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
  • 批准号:
    10568864
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
  • 批准号:
    10598376
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
  • 批准号:
    10910337
  • 财政年份:
    2023
  • 资助金额:
    $ 10.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了